London and Malmö—Thoma Bravo, a leading software investment firm, today announced the completion of its growth investment in Hypergene, a Swedish software-as-a-service (SaaS) company for planning and performance management. Thoma Bravo’s majority investment in Hypergene is expected to enable the company to focus even more on product development and its European growth strategy.

Founded in 2000, Hypergene is one of the leading players in Corporate Performance Management and Project & Portfolio Management (xP&A) in Northern Europe. The company develops and designs software which is used by the C-Suite and Office of Finance for strategic planning, budgeting and forecasting and project & portfolio management. Hypergene is headquartered in Malmö, Sweden, and employs over 200 people across eight offices in Sweden, Norway and Germany.

“This is the beginning of a new and exciting chapter for Hypergene,” said Irina Hemmers, a Partner at Thoma Bravo. “We look forward to supporting the company as it expands its product offering and pursues its European growth strategy.”

This is Thoma Bravo's third investment by its Europe-based team, following recent investments earlier this year in Logex and EQS and building on the opening of its London office in 2022 led by Irina Hemmers. It is also the company’s second investment in the Nordics following the acquisition of Mercell in 2022.

William Blair served as exclusive financial advisor to Hypergene and White & Case served as legal counsel. Hannes Snellman and Kirkland and Ellis served as legal counsel to Thoma Bravo.

ENDS

About Thoma Bravo
Thoma Bravo is one of the largest software investors in the world, with approximately US$134 billion in assets under management as of September 30, 2023. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo's deep sector knowledge and strategic and operational expertise, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20 years, the firm has acquired or invested in more than 455 companies representing over US$255 billion in enterprise value (including control and non-control investments). The firm has offices in Chicago, London, Miami, New York and San
Francisco. For more information, visit Thoma Bravo's website at thomabravo.com.

About Hypergene
Hypergene is a SaaS company in the North European market for corporate performance management and project & portfolio management. The company helps streamline the customer's budget and forecasting processes, follow up their operations using advanced analysis and reporting functionality, and work with strategic management in a manner that breaks down overall plans into goals, KPIs and activities throughout the organisation. The customer can choose selected elements or opt for a comprehensive solution. Hypergene target medium and large organisations in both the private and public sectors. The typical purchaser of the product is a forward-looking CFO/finance director who wants to create better conditions for processes within corporate performance management and project & portfolio management. The users include the organisation’s top management, managers and decision-makers, as well as controllers and other roles that contribute to the planning processes. Hypergene is headquartered in Malmö, Sweden, and employs over 200
people across eight offices in Sweden, Norway and Germany.